Illumina, Inc.
ILMN- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001110803
In the last 90 days, Illumina, Inc. insiders filed 0 open-market purchases and 5 sales; 944 institutions reported holding it in 13F filings for Q2 2026, worth $27.5B in total; ARK Invest is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 31, 2026, 1:12 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 14, 2025 | Jan 9, 2024 | Jan 11, 2023 | Jan 11, 2022 |
| Revenue | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B |
| Cost of revenue | $1.47B | $1.51B | $1.76B | $1.61B | $1.37B |
| Gross profit | $2.87B | $2.86B | $2.74B | $2.97B | $3.15B |
| Operating expenses | $2.06B | $3.69B | $3.81B | $7.15B | $3.28B |
| Research and development | $967.0M | $1.17B | $1.35B | $1.32B | $1.19B |
| Selling, general and administrative | $1.09B | $1.09B | $1.61B | $1.30B | $2.09B |
| Operating income | $807.0M | -$833.0M | -$1.07B | -$4.18B | -$123.0M |
| Interest expense | – | – | $77.0M | $26.0M | $61.0M |
| Income tax | $236.0M | $44.0M | $44.0M | $68.0M | $122.0M |
| Net income | $850.0M | -$1.22B | -$1.16B | -$4.40B | $762.0M |
| EPS, basic | $5.47 | $-7.69 | $-7.34 | $-28.00 | $5.07 |
| EPS, diluted | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 |
| Weighted shares, basic | 155.0M | 159.0M | 158.0M | 157.0M | 150.0M |
| Weighted shares, diluted | 156.0M | 159.0M | 158.0M | 157.0M | 151.0M |
| Margins and growth | |||||
| Gross margin | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% |
| Operating margin | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% |
| Net margin | 19.6% | -28.0% | -25.8% | -96.1% | 16.8% |
| Revenue growth, year over year | −0.7% | −2.9% | −1.7% | +1.3% | +39.7% |
| Net income growth, year over year | – | – | – | −678.0% | +16.2% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 14, 2025 | Jan 9, 2024 | Jan 11, 2023 | Jan 11, 2022 |
| Short-term investments | $215.0M | $93.0M | $6.00M | $26.0M | $107.0M |
| Accounts receivable | $854.0M | $735.0M | $734.0M | $671.0M | $648.0M |
| Inventory | $564.0M | $547.0M | $587.0M | $568.0M | $431.0M |
| Total current assets | $3.29B | $2.75B | $2.61B | $3.56B | $2.71B |
| Property, plant and equipment | $759.0M | $815.0M | $1.01B | $1.09B | $1.02B |
| Goodwill | $1.11B | $1.11B | $2.54B | $3.24B | $7.11B |
| Intangible assets | $210.0M | $295.0M | $2.99B | $3.29B | $3.25B |
| Total assets | $6.64B | $6.30B | $10.1B | $12.3B | $15.2B |
| Accounts payable | $240.0M | $221.0M | $245.0M | $293.0M | $332.0M |
| Total current liabilities | $1.58B | $1.55B | $1.57B | $2.77B | $1.09B |
| Shareholders' equity | $2.72B | $2.37B | $5.75B | $6.60B | $10.7B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 14, 2025 | Jan 9, 2024 | Jan 11, 2023 | Jan 11, 2022 |
| Operating cash flow | $1.08B | $837.0M | $478.0M | $392.0M | $545.0M |
| Capital expenditures | $148.0M | $128.0M | $195.0M | $286.0M | $208.0M |
| Free cash flow | $931.0M | $709.0M | $283.0M | $106.0M | $337.0M |
| Depreciation and amortization | $270.0M | $354.0M | $432.0M | $394.0M | $251.0M |
| Stock-based compensation | $275.0M | $370.0M | $380.0M | $366.0M | $754.0M |
| Share buybacks | $742.0M | $116.0M | – | $0 | $0 |
| Investing cash flow | -$55.0M | -$178.0M | -$231.0M | -$591.0M | -$1.07B |
| Financing cash flow | -$744.0M | -$570.0M | -$1.21B | $1.00B | -$51.0M |
| Net change in cash | $291.0M | $79.0M | -$963.0M | $779.0M | -$578.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 6.3% | 8.5% | 8.4% | 8.0% | 16.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 23, 2026 | 151.2M | −1.0% | SEC |
| Jul 24, 2026 | 151.0M | −1.8% | SEC |
| Apr 24, 2026 | 151.3M | −4.4% | SEC |
| Feb 6, 2026 | 152.9M | −3.5% | SEC |
| Oct 24, 2025 | 152.8M | −3.7% | SEC |
| Jul 25, 2025 | 153.7M | −3.5% | SEC |
| May 2, 2025 | 158.3M | −0.6% | SEC |
| Feb 7, 2025 | 158.4M | −0.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.